Dr Neil Murphy is a cancer epidemiologist in the Department of Epidemiology and Biostatistics at Imperial College, London. He received a BSc in Nutrition from King’s College London, and an MSc in Modern Epidemiology and PhD in Epidemiology from Imperial College London. Dr Murphy has a major interest in understanding the aetiological mechanisms underlying the development of cancer. He has recently begun a portfolio of research aimed at investigating the metabolic and endocrinological influences on colorectal cancer, and has taken the lead in analyses of data from European and U.S. prospective cohort studies, including the European Prospective Investigation into Cancer and Nutrition (EPIC), UK Biobank, Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial, and the Women's Health Initiative (WHI).
et al., 2022, Metabolic signatures of healthy lifestyle patterns and colorectal cancer risk in a European cohort, Clinical Gastroenterology and Hepatology, Vol:20, ISSN:1542-3565, Pages:e1061-e1082
et al., 2022, Diabetes mellitus in relation to colorectal tumor molecular subtypes: A pooled analysis of more than 9000 cases, International Journal of Cancer, ISSN:0020-7136
et al., 2022, Risk Stratification for Early-Onset Colorectal Cancer Using a Combination of Genetic and Environmental Risk Scores: An International Multi-Center Study., J Natl Cancer Inst, Vol:114, Pages:528-539
et al., 2022, Associations Between Glycemic Traits and Colorectal Cancer: A Mendelian Randomization Analysis, Jnci-journal of the National Cancer Institute, ISSN:0027-8874
Murphy N, Campbell PT, Gunter MJ, 2021, Are sugar-sweetened beverages contributing to the rising occurrence of colorectal cancer in young adults?, Gut, Vol:70, ISSN:0017-5749, Pages:2222-2223